Rhenman & Partners Asset Management AB - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 251 filers reported holding BLUEBIRD BIO INC in Q3 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2020$5,816,000
-11.6%
107,7970.0%0.52%
-27.3%
Q2 2020$6,580,000
+113.7%
107,797
+60.9%
0.71%
+65.0%
Q1 2020$3,079,000
-38.4%
67,000
+17.5%
0.43%
-21.4%
Q4 2019$5,002,000
+4.8%
57,000
+9.6%
0.55%
-8.5%
Q3 2019$4,775,000
-46.4%
52,000
-25.7%
0.60%
-38.9%
Q2 2019$8,904,000
+2.9%
70,000
+27.3%
0.98%
-3.1%
Q1 2019$8,653,000
-26.0%
55,000
-53.3%
1.01%
-24.3%
Q4 2018$11,691,000117,8501.34%
Other shareholders
BLUEBIRD BIO INC shareholders Q3 2019
NameSharesValueWeighting ↓
AlpInvest Partners B.V. 46,264$3,958,0007.80%
RTW INVESTMENTS, LP 151,594$12,969,0004.03%
APIS CAPITAL ADVISORS, LLC 30,870$2,640,0003.65%
Parametrica Management Ltd 4,084$349,0002.20%
Eventide Asset Management 419,600$35,897,0002.09%
RA Capital Management 167,367$14,318,0002.06%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 483,000$41,321,0001.60%
Taylor Wealth Management Partners 38,184$3,267,0001.58%
Orbimed Advisors 1,188,900$101,710,0001.03%
CABOT WEALTH MANAGEMENT INC 34,195$2,925,0000.81%
View complete list of BLUEBIRD BIO INC shareholders